Cas:4146-73-0 lead trifluoroacetate manufacturer & supplier

We serve Chemical Name:lead trifluoroacetate CAS:4146-73-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

lead trifluoroacetate

Chemical Name:lead trifluoroacetate
CAS.NO:4146-73-0
Synonyms:lead trifluoroacetate;MFCD00061594;Blei-bis-trifluoracetat;Bleitrifluoroacetat
Molecular Formula:C4F6O4Pb
Molecular Weight:433.23100
HS Code:

Physical and Chemical Properties:
Melting point:147-153ºC
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:52.60000
Exact Mass:433.94700
LogP:0.73160

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2291 6.1/PG 3
Packing Group:III


Contact us for information like lead trifluoroacetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Bleitrifluoroacetat physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Blei-bis-trifluoracetat Use and application,lead trifluoroacetate technical grade,usp/ep/jp grade.


Related News: The patient, who arrived from Wuhan, is ��stable and under medical care,�� the ministry said in a statement, adding there is ��no cause for concern�� for the public. lead trifluoroacetate manufacturer After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing. lead trifluoroacetate supplier In addition, due to environmental constraints, Yancheng Lianhua’s first pesticide project ANBE was put into operation at a slower pace than expected, and other pesticide projects were also put into operation. lead trifluoroacetate vendor The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses. lead trifluoroacetate factory The patient, who arrived from Wuhan, is ��stable and under medical care,�� the ministry said in a statement, adding there is ��no cause for concern�� for the public.